Global Biguanides Market Size and Forecast to 2029: Revenue, Growth, and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the biguanides market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Biguanides Market Size Today And What Will Its Value Be At The End Of 2029?

The biguanides market size has demonstrated consistent expansion in recent years. This market is projected to expand from $4.96 billion in 2024 to $5.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.1%. Factors contributing to this historical growth include an escalating demand for oral hypoglycemic drugs, an expanding geriatric demographic, increasing obesity levels, and greater understanding of diabetes management.

The biguanides market size is anticipated to experience steady growth in the upcoming years, with projections indicating it will reach $5.81 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 3.2%. This expansion during the forecast period is driven by the increasing adoption of combination therapies, advancements in drug delivery technologies, heightened investment in research and development, rising healthcare expenditure, and broader applications in the treatment of polycystic ovary syndrome. Prominent trends expected in this timeframe include an escalating focus on developing extended-release formulations, a growing preference for fixed-dose combination therapies, expanding applications in oncology, and the emergence of novel biguanides featuring improved efficacy and safety profiles.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp

Which Key Drivers Are Powering Growth In The Biguanides Market?

The anticipated expansion of the biguanides market is significantly influenced by the increasing prevalence of diabetes. This condition, diabetes, is a long-term metabolic ailment marked by elevated blood sugar (glucose) levels, stemming from the body’s insufficient insulin production. Various elements contribute to the growth in diabetes cases, such as shifts in lifestyle, an aging population, inherited predispositions, enhanced diagnostic methods, and environmental factors. Biguanides, notably metformin, address diabetes by enhancing insulin sensitivity, decreasing glucose generation in the liver, and reducing blood sugar concentrations in those with type 2 diabetes. An illustrative example comes from March 2024, where the Office for Health Improvement & Disparities, a UK-based government department, reported that from March 2022 to March 2023, there was a 22% increase in the proportion of individuals with type 1 diabetes undergoing all eight recommended care processes, and a 21% increase for type 2 diabetes, with the percentage reaching target HbA1c levels climbing to 37.9%, which represents an unprecedented high. Consequently, the expanding occurrence of diabetes is fueling the expansion of the biguanides market.

Which Segment Categories Are Driving Maximum Growth In The Biguanides Market?

The biguanides market covered in this report is segmented –

1) By Type: Metformin, Phenformin, Other Types

2) By Dosage Form: Tablets, Oral Solutions

3) By Formulation: Immediate Release, Extended Release

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

2) By Phenformin: Phenformin Hydrochloride

3) By Other Types: Buformin, Metformin Combinations

What Key Trends Are Driving Growth In The Biguanides Market?

Major companies operating in the biguanide market are concentrating on developing advanced solutions, such as extended-release biguanide drugs, to enhance patient compliance, improve therapeutic efficacy, and reduce side effects. An extended-release biguanide is a medication formulated to gradually release its active component, ensuring consistent blood levels and better glycemic control for diabetes patients, thereby improving adherence to the treatment regimen. For instance, in August 2023, Dr. Reddy’s Laboratories, an India-based biotechnology company, launched extended-release versions of saxagliptin and metformin hydrochloride drugs. This product, a generic version of KOMBIGLYZE XR, was approved by the US Food and Drug Administration (USFDA) and combines saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide. It is designed to optimize glycemic control in adults with type 2 diabetes mellitus and is intended for use in conjunction with diet and exercise. The extended-release formulation additionally helps improve patient adherence and overall efficacy.

Who Are The Leading Companies Driving The Biguanides Market?

Major companies operating in the biguanides market are Cardinal Health Inc., Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi-Aventis LLC, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Company Limited, Novo Nordisk A/S, Viatris Inc., Daiichi Sankyo Company Limited, Wanbury Ltd., Boehringer Ingelheim International GmbH, Intas Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Shionogi & Co Ltd., Dr. Reddy’s Laboratories, Lupin Limited, Zydus Lifesciences Limited, Apotex Inc., Torrent Pharmaceuticals Limited, Panacea Biotech Ltd., Auro Laboratories Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

Which Region Holds The Largest Share In The Biguanides Market Today?

Asia-Pacific was the largest region in the biguanides market in 2024. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15735&type=smp

Browse Through More Reports Similar to the Global Biguanides Market 2025, By The Business Research Company

Small Molecule Api Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-molecule-api-global-market-report

Softgel Capsules Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/softgel-capsules-global-market-report

Urothelial Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urothelial-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795